Global Denosumab Injection Market Growth 2026-2032
The global Denosumab Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Denosumab injection is a medication used primarily to treat bone-related conditions such as osteoporosis, particularly in patients at high risk of fractures, as well as for bone loss associated with cancer.
United States market for Denosumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Denosumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Denosumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Denosumab Injection players cover Amgen, Sandoz Biologics, Amneal, Fresenius Kabi, Dr. Reddy's Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Denosumab Injection Industry Forecast? looks at past sales and reviews total world Denosumab Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Denosumab Injection sales for 2026 through 2032. With Denosumab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Denosumab Injection industry.
This Insight Report provides a comprehensive analysis of the global Denosumab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Denosumab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Denosumab Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Denosumab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Denosumab Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Denosumab Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Denosumab Injection market?
What factors are driving Denosumab Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Denosumab Injection market opportunities vary by end market size?
How does Denosumab Injection break out by Type, by Application?
Denosumab injection is a medication used primarily to treat bone-related conditions such as osteoporosis, particularly in patients at high risk of fractures, as well as for bone loss associated with cancer.
United States market for Denosumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Denosumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Denosumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Denosumab Injection players cover Amgen, Sandoz Biologics, Amneal, Fresenius Kabi, Dr. Reddy's Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Denosumab Injection Industry Forecast? looks at past sales and reviews total world Denosumab Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Denosumab Injection sales for 2026 through 2032. With Denosumab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Denosumab Injection industry.
This Insight Report provides a comprehensive analysis of the global Denosumab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Denosumab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Denosumab Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Denosumab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Denosumab Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Denosumab Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 60mg per Vial
- 120mg per Vial
- Giant Cell Tumor of Bone
- Multiple Myeloma
- Hypercalcemia of Malignant Tumors
- Osteolytic Bone Metastasis of Solid Tumors
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen
- Sandoz Biologics
- Amneal
- Fresenius Kabi
- Dr. Reddy's Laboratories
- Alvotech
- Lotus Pharmaceutical
- Intas Pharmaceuticals
- Qilu Pharmaceutical
- Jiangsu T-mab BioPharma
- Boan Biotech
What is the 10-year outlook for the global Denosumab Injection market?
What factors are driving Denosumab Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Denosumab Injection market opportunities vary by end market size?
How does Denosumab Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Denosumab Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Denosumab Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Denosumab Injection by Country/Region, 2021, 2025 & 2032
2.2 Denosumab Injection Segment by Type
2.2.1 60mg per Vial
2.2.2 120mg per Vial
2.2.3 Denosumab Injection Sales by Type
2.2.3.1 Global Denosumab Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Denosumab Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Denosumab Injection Sale Price by Type (2021-2026)
2.3 Denosumab Injection Segment by Application
2.3.1 Giant Cell Tumor of Bone
2.3.2 Multiple Myeloma
2.3.3 Hypercalcemia of Malignant Tumors
2.3.4 Osteolytic Bone Metastasis of Solid Tumors
2.3.5 Denosumab Injection Sales by Application
2.3.5.1 Global Denosumab Injection Sale Market Share by Application (2021-2026)
2.3.5.2 Global Denosumab Injection Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Denosumab Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Denosumab Injection Breakdown Data by Company
3.1.1 Global Denosumab Injection Annual Sales by Company (2021-2026)
3.1.2 Global Denosumab Injection Sales Market Share by Company (2021-2026)
3.2 Global Denosumab Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Denosumab Injection Revenue by Company (2021-2026)
3.2.2 Global Denosumab Injection Revenue Market Share by Company (2021-2026)
3.3 Global Denosumab Injection Sale Price by Company
3.4 Key Manufacturers Denosumab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Denosumab Injection Product Location Distribution
3.4.2 Players Denosumab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DENOSUMAB INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Denosumab Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Denosumab Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Denosumab Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Denosumab Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Denosumab Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Denosumab Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Denosumab Injection Sales Growth
4.4 APAC Denosumab Injection Sales Growth
4.5 Europe Denosumab Injection Sales Growth
4.6 Middle East & Africa Denosumab Injection Sales Growth
5 AMERICAS
5.1 Americas Denosumab Injection Sales by Country
5.1.1 Americas Denosumab Injection Sales by Country (2021-2026)
5.1.2 Americas Denosumab Injection Revenue by Country (2021-2026)
5.2 Americas Denosumab Injection Sales by Type (2021-2026)
5.3 Americas Denosumab Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Denosumab Injection Sales by Region
6.1.1 APAC Denosumab Injection Sales by Region (2021-2026)
6.1.2 APAC Denosumab Injection Revenue by Region (2021-2026)
6.2 APAC Denosumab Injection Sales by Type (2021-2026)
6.3 APAC Denosumab Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Denosumab Injection by Country
7.1.1 Europe Denosumab Injection Sales by Country (2021-2026)
7.1.2 Europe Denosumab Injection Revenue by Country (2021-2026)
7.2 Europe Denosumab Injection Sales by Type (2021-2026)
7.3 Europe Denosumab Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Denosumab Injection by Country
8.1.1 Middle East & Africa Denosumab Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Denosumab Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Denosumab Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Denosumab Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Denosumab Injection
10.3 Manufacturing Process Analysis of Denosumab Injection
10.4 Industry Chain Structure of Denosumab Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Denosumab Injection Distributors
11.3 Denosumab Injection Customer
12 WORLD FORECAST REVIEW FOR DENOSUMAB INJECTION BY GEOGRAPHIC REGION
12.1 Global Denosumab Injection Market Size Forecast by Region
12.1.1 Global Denosumab Injection Forecast by Region (2027-2032)
12.1.2 Global Denosumab Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Denosumab Injection Forecast by Type (2027-2032)
12.7 Global Denosumab Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Denosumab Injection Product Portfolios and Specifications
13.1.3 Amgen Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Sandoz Biologics
13.2.1 Sandoz Biologics Company Information
13.2.2 Sandoz Biologics Denosumab Injection Product Portfolios and Specifications
13.2.3 Sandoz Biologics Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sandoz Biologics Main Business Overview
13.2.5 Sandoz Biologics Latest Developments
13.3 Amneal
13.3.1 Amneal Company Information
13.3.2 Amneal Denosumab Injection Product Portfolios and Specifications
13.3.3 Amneal Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Amneal Main Business Overview
13.3.5 Amneal Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Denosumab Injection Product Portfolios and Specifications
13.4.3 Fresenius Kabi Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Dr. Reddy's Laboratories
13.5.1 Dr. Reddy's Laboratories Company Information
13.5.2 Dr. Reddy's Laboratories Denosumab Injection Product Portfolios and Specifications
13.5.3 Dr. Reddy's Laboratories Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Dr. Reddy's Laboratories Main Business Overview
13.5.5 Dr. Reddy's Laboratories Latest Developments
13.6 Alvotech
13.6.1 Alvotech Company Information
13.6.2 Alvotech Denosumab Injection Product Portfolios and Specifications
13.6.3 Alvotech Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Alvotech Main Business Overview
13.6.5 Alvotech Latest Developments
13.7 Lotus Pharmaceutical
13.7.1 Lotus Pharmaceutical Company Information
13.7.2 Lotus Pharmaceutical Denosumab Injection Product Portfolios and Specifications
13.7.3 Lotus Pharmaceutical Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Lotus Pharmaceutical Main Business Overview
13.7.5 Lotus Pharmaceutical Latest Developments
13.8 Intas Pharmaceuticals
13.8.1 Intas Pharmaceuticals Company Information
13.8.2 Intas Pharmaceuticals Denosumab Injection Product Portfolios and Specifications
13.8.3 Intas Pharmaceuticals Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Intas Pharmaceuticals Main Business Overview
13.8.5 Intas Pharmaceuticals Latest Developments
13.9 Qilu Pharmaceutical
13.9.1 Qilu Pharmaceutical Company Information
13.9.2 Qilu Pharmaceutical Denosumab Injection Product Portfolios and Specifications
13.9.3 Qilu Pharmaceutical Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Qilu Pharmaceutical Main Business Overview
13.9.5 Qilu Pharmaceutical Latest Developments
13.10 Jiangsu T-mab BioPharma
13.10.1 Jiangsu T-mab BioPharma Company Information
13.10.2 Jiangsu T-mab BioPharma Denosumab Injection Product Portfolios and Specifications
13.10.3 Jiangsu T-mab BioPharma Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Jiangsu T-mab BioPharma Main Business Overview
13.10.5 Jiangsu T-mab BioPharma Latest Developments
13.11 Boan Biotech
13.11.1 Boan Biotech Company Information
13.11.2 Boan Biotech Denosumab Injection Product Portfolios and Specifications
13.11.3 Boan Biotech Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Boan Biotech Main Business Overview
13.11.5 Boan Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Denosumab Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Denosumab Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Denosumab Injection by Country/Region, 2021, 2025 & 2032
2.2 Denosumab Injection Segment by Type
2.2.1 60mg per Vial
2.2.2 120mg per Vial
2.2.3 Denosumab Injection Sales by Type
2.2.3.1 Global Denosumab Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Denosumab Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Denosumab Injection Sale Price by Type (2021-2026)
2.3 Denosumab Injection Segment by Application
2.3.1 Giant Cell Tumor of Bone
2.3.2 Multiple Myeloma
2.3.3 Hypercalcemia of Malignant Tumors
2.3.4 Osteolytic Bone Metastasis of Solid Tumors
2.3.5 Denosumab Injection Sales by Application
2.3.5.1 Global Denosumab Injection Sale Market Share by Application (2021-2026)
2.3.5.2 Global Denosumab Injection Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Denosumab Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Denosumab Injection Breakdown Data by Company
3.1.1 Global Denosumab Injection Annual Sales by Company (2021-2026)
3.1.2 Global Denosumab Injection Sales Market Share by Company (2021-2026)
3.2 Global Denosumab Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Denosumab Injection Revenue by Company (2021-2026)
3.2.2 Global Denosumab Injection Revenue Market Share by Company (2021-2026)
3.3 Global Denosumab Injection Sale Price by Company
3.4 Key Manufacturers Denosumab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Denosumab Injection Product Location Distribution
3.4.2 Players Denosumab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DENOSUMAB INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Denosumab Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Denosumab Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Denosumab Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Denosumab Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Denosumab Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Denosumab Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Denosumab Injection Sales Growth
4.4 APAC Denosumab Injection Sales Growth
4.5 Europe Denosumab Injection Sales Growth
4.6 Middle East & Africa Denosumab Injection Sales Growth
5 AMERICAS
5.1 Americas Denosumab Injection Sales by Country
5.1.1 Americas Denosumab Injection Sales by Country (2021-2026)
5.1.2 Americas Denosumab Injection Revenue by Country (2021-2026)
5.2 Americas Denosumab Injection Sales by Type (2021-2026)
5.3 Americas Denosumab Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Denosumab Injection Sales by Region
6.1.1 APAC Denosumab Injection Sales by Region (2021-2026)
6.1.2 APAC Denosumab Injection Revenue by Region (2021-2026)
6.2 APAC Denosumab Injection Sales by Type (2021-2026)
6.3 APAC Denosumab Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Denosumab Injection by Country
7.1.1 Europe Denosumab Injection Sales by Country (2021-2026)
7.1.2 Europe Denosumab Injection Revenue by Country (2021-2026)
7.2 Europe Denosumab Injection Sales by Type (2021-2026)
7.3 Europe Denosumab Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Denosumab Injection by Country
8.1.1 Middle East & Africa Denosumab Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Denosumab Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Denosumab Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Denosumab Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Denosumab Injection
10.3 Manufacturing Process Analysis of Denosumab Injection
10.4 Industry Chain Structure of Denosumab Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Denosumab Injection Distributors
11.3 Denosumab Injection Customer
12 WORLD FORECAST REVIEW FOR DENOSUMAB INJECTION BY GEOGRAPHIC REGION
12.1 Global Denosumab Injection Market Size Forecast by Region
12.1.1 Global Denosumab Injection Forecast by Region (2027-2032)
12.1.2 Global Denosumab Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Denosumab Injection Forecast by Type (2027-2032)
12.7 Global Denosumab Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Denosumab Injection Product Portfolios and Specifications
13.1.3 Amgen Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Sandoz Biologics
13.2.1 Sandoz Biologics Company Information
13.2.2 Sandoz Biologics Denosumab Injection Product Portfolios and Specifications
13.2.3 Sandoz Biologics Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sandoz Biologics Main Business Overview
13.2.5 Sandoz Biologics Latest Developments
13.3 Amneal
13.3.1 Amneal Company Information
13.3.2 Amneal Denosumab Injection Product Portfolios and Specifications
13.3.3 Amneal Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Amneal Main Business Overview
13.3.5 Amneal Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Denosumab Injection Product Portfolios and Specifications
13.4.3 Fresenius Kabi Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Dr. Reddy's Laboratories
13.5.1 Dr. Reddy's Laboratories Company Information
13.5.2 Dr. Reddy's Laboratories Denosumab Injection Product Portfolios and Specifications
13.5.3 Dr. Reddy's Laboratories Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Dr. Reddy's Laboratories Main Business Overview
13.5.5 Dr. Reddy's Laboratories Latest Developments
13.6 Alvotech
13.6.1 Alvotech Company Information
13.6.2 Alvotech Denosumab Injection Product Portfolios and Specifications
13.6.3 Alvotech Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Alvotech Main Business Overview
13.6.5 Alvotech Latest Developments
13.7 Lotus Pharmaceutical
13.7.1 Lotus Pharmaceutical Company Information
13.7.2 Lotus Pharmaceutical Denosumab Injection Product Portfolios and Specifications
13.7.3 Lotus Pharmaceutical Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Lotus Pharmaceutical Main Business Overview
13.7.5 Lotus Pharmaceutical Latest Developments
13.8 Intas Pharmaceuticals
13.8.1 Intas Pharmaceuticals Company Information
13.8.2 Intas Pharmaceuticals Denosumab Injection Product Portfolios and Specifications
13.8.3 Intas Pharmaceuticals Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Intas Pharmaceuticals Main Business Overview
13.8.5 Intas Pharmaceuticals Latest Developments
13.9 Qilu Pharmaceutical
13.9.1 Qilu Pharmaceutical Company Information
13.9.2 Qilu Pharmaceutical Denosumab Injection Product Portfolios and Specifications
13.9.3 Qilu Pharmaceutical Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Qilu Pharmaceutical Main Business Overview
13.9.5 Qilu Pharmaceutical Latest Developments
13.10 Jiangsu T-mab BioPharma
13.10.1 Jiangsu T-mab BioPharma Company Information
13.10.2 Jiangsu T-mab BioPharma Denosumab Injection Product Portfolios and Specifications
13.10.3 Jiangsu T-mab BioPharma Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Jiangsu T-mab BioPharma Main Business Overview
13.10.5 Jiangsu T-mab BioPharma Latest Developments
13.11 Boan Biotech
13.11.1 Boan Biotech Company Information
13.11.2 Boan Biotech Denosumab Injection Product Portfolios and Specifications
13.11.3 Boan Biotech Denosumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Boan Biotech Main Business Overview
13.11.5 Boan Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Denosumab Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Denosumab Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 60mg per Vial
Table 4. Major Players of 120mg per Vial
Table 5. Global Denosumab Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Denosumab Injection Sales Market Share by Type (2021-2026)
Table 7. Global Denosumab Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Denosumab Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Denosumab Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Denosumab Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Denosumab Injection Sale Market Share by Application (2021-2026)
Table 12. Global Denosumab Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Denosumab Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Denosumab Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Denosumab Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Denosumab Injection Sales Market Share by Company (2021-2026)
Table 17. Global Denosumab Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Denosumab Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Denosumab Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Denosumab Injection Producing Area Distribution and Sales Area
Table 21. Players Denosumab Injection Products Offered
Table 22. Denosumab Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Denosumab Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Denosumab Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Denosumab Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Denosumab Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Denosumab Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Denosumab Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Denosumab Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Denosumab Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Denosumab Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Denosumab Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Denosumab Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Denosumab Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Denosumab Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Denosumab Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Denosumab Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Denosumab Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Denosumab Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Denosumab Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Denosumab Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Denosumab Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Denosumab Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Denosumab Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Denosumab Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Denosumab Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Denosumab Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Denosumab Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Denosumab Injection
Table 52. Key Market Challenges & Risks of Denosumab Injection
Table 53. Key Industry Trends of Denosumab Injection
Table 54. Denosumab Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Denosumab Injection Distributors List
Table 57. Denosumab Injection Customer List
Table 58. Global Denosumab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Denosumab Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Denosumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Denosumab Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Denosumab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Denosumab Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Denosumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Denosumab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Denosumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Denosumab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Denosumab Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Denosumab Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Denosumab Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Denosumab Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Amgen Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Amgen Denosumab Injection Product Portfolios and Specifications
Table 74. Amgen Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Amgen Main Business
Table 76. Amgen Latest Developments
Table 77. Sandoz Biologics Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Sandoz Biologics Denosumab Injection Product Portfolios and Specifications
Table 79. Sandoz Biologics Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Sandoz Biologics Main Business
Table 81. Sandoz Biologics Latest Developments
Table 82. Amneal Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Amneal Denosumab Injection Product Portfolios and Specifications
Table 84. Amneal Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Amneal Main Business
Table 86. Amneal Latest Developments
Table 87. Fresenius Kabi Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Fresenius Kabi Denosumab Injection Product Portfolios and Specifications
Table 89. Fresenius Kabi Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Fresenius Kabi Main Business
Table 91. Fresenius Kabi Latest Developments
Table 92. Dr. Reddy's Laboratories Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Dr. Reddy's Laboratories Denosumab Injection Product Portfolios and Specifications
Table 94. Dr. Reddy's Laboratories Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Dr. Reddy's Laboratories Main Business
Table 96. Dr. Reddy's Laboratories Latest Developments
Table 97. Alvotech Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Alvotech Denosumab Injection Product Portfolios and Specifications
Table 99. Alvotech Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Alvotech Main Business
Table 101. Alvotech Latest Developments
Table 102. Lotus Pharmaceutical Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Lotus Pharmaceutical Denosumab Injection Product Portfolios and Specifications
Table 104. Lotus Pharmaceutical Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Lotus Pharmaceutical Main Business
Table 106. Lotus Pharmaceutical Latest Developments
Table 107. Intas Pharmaceuticals Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Intas Pharmaceuticals Denosumab Injection Product Portfolios and Specifications
Table 109. Intas Pharmaceuticals Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Intas Pharmaceuticals Main Business
Table 111. Intas Pharmaceuticals Latest Developments
Table 112. Qilu Pharmaceutical Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Qilu Pharmaceutical Denosumab Injection Product Portfolios and Specifications
Table 114. Qilu Pharmaceutical Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Qilu Pharmaceutical Main Business
Table 116. Qilu Pharmaceutical Latest Developments
Table 117. Jiangsu T-mab BioPharma Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Jiangsu T-mab BioPharma Denosumab Injection Product Portfolios and Specifications
Table 119. Jiangsu T-mab BioPharma Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Jiangsu T-mab BioPharma Main Business
Table 121. Jiangsu T-mab BioPharma Latest Developments
Table 122. Boan Biotech Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Boan Biotech Denosumab Injection Product Portfolios and Specifications
Table 124. Boan Biotech Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Boan Biotech Main Business
Table 126. Boan Biotech Latest Developments
Table 1. Denosumab Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Denosumab Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 60mg per Vial
Table 4. Major Players of 120mg per Vial
Table 5. Global Denosumab Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Denosumab Injection Sales Market Share by Type (2021-2026)
Table 7. Global Denosumab Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Denosumab Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Denosumab Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Denosumab Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Denosumab Injection Sale Market Share by Application (2021-2026)
Table 12. Global Denosumab Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Denosumab Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Denosumab Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Denosumab Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Denosumab Injection Sales Market Share by Company (2021-2026)
Table 17. Global Denosumab Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Denosumab Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Denosumab Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Denosumab Injection Producing Area Distribution and Sales Area
Table 21. Players Denosumab Injection Products Offered
Table 22. Denosumab Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Denosumab Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Denosumab Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Denosumab Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Denosumab Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Denosumab Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Denosumab Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Denosumab Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Denosumab Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Denosumab Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Denosumab Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Denosumab Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Denosumab Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Denosumab Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Denosumab Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Denosumab Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Denosumab Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Denosumab Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Denosumab Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Denosumab Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Denosumab Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Denosumab Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Denosumab Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Denosumab Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Denosumab Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Denosumab Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Denosumab Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Denosumab Injection
Table 52. Key Market Challenges & Risks of Denosumab Injection
Table 53. Key Industry Trends of Denosumab Injection
Table 54. Denosumab Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Denosumab Injection Distributors List
Table 57. Denosumab Injection Customer List
Table 58. Global Denosumab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Denosumab Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Denosumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Denosumab Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Denosumab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Denosumab Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Denosumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Denosumab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Denosumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Denosumab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Denosumab Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Denosumab Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Denosumab Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Denosumab Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Amgen Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Amgen Denosumab Injection Product Portfolios and Specifications
Table 74. Amgen Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Amgen Main Business
Table 76. Amgen Latest Developments
Table 77. Sandoz Biologics Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Sandoz Biologics Denosumab Injection Product Portfolios and Specifications
Table 79. Sandoz Biologics Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Sandoz Biologics Main Business
Table 81. Sandoz Biologics Latest Developments
Table 82. Amneal Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Amneal Denosumab Injection Product Portfolios and Specifications
Table 84. Amneal Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Amneal Main Business
Table 86. Amneal Latest Developments
Table 87. Fresenius Kabi Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Fresenius Kabi Denosumab Injection Product Portfolios and Specifications
Table 89. Fresenius Kabi Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Fresenius Kabi Main Business
Table 91. Fresenius Kabi Latest Developments
Table 92. Dr. Reddy's Laboratories Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Dr. Reddy's Laboratories Denosumab Injection Product Portfolios and Specifications
Table 94. Dr. Reddy's Laboratories Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Dr. Reddy's Laboratories Main Business
Table 96. Dr. Reddy's Laboratories Latest Developments
Table 97. Alvotech Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Alvotech Denosumab Injection Product Portfolios and Specifications
Table 99. Alvotech Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Alvotech Main Business
Table 101. Alvotech Latest Developments
Table 102. Lotus Pharmaceutical Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Lotus Pharmaceutical Denosumab Injection Product Portfolios and Specifications
Table 104. Lotus Pharmaceutical Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Lotus Pharmaceutical Main Business
Table 106. Lotus Pharmaceutical Latest Developments
Table 107. Intas Pharmaceuticals Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Intas Pharmaceuticals Denosumab Injection Product Portfolios and Specifications
Table 109. Intas Pharmaceuticals Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Intas Pharmaceuticals Main Business
Table 111. Intas Pharmaceuticals Latest Developments
Table 112. Qilu Pharmaceutical Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Qilu Pharmaceutical Denosumab Injection Product Portfolios and Specifications
Table 114. Qilu Pharmaceutical Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Qilu Pharmaceutical Main Business
Table 116. Qilu Pharmaceutical Latest Developments
Table 117. Jiangsu T-mab BioPharma Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Jiangsu T-mab BioPharma Denosumab Injection Product Portfolios and Specifications
Table 119. Jiangsu T-mab BioPharma Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Jiangsu T-mab BioPharma Main Business
Table 121. Jiangsu T-mab BioPharma Latest Developments
Table 122. Boan Biotech Basic Information, Denosumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Boan Biotech Denosumab Injection Product Portfolios and Specifications
Table 124. Boan Biotech Denosumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Boan Biotech Main Business
Table 126. Boan Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Denosumab Injection
Figure 2. Denosumab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Denosumab Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Denosumab Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Denosumab Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Denosumab Injection Sales Market Share by Country/Region (2025)
Figure 10. Denosumab Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 60mg per Vial
Figure 12. Product Picture of 120mg per Vial
Figure 13. Global Denosumab Injection Sales Market Share by Type in 2026
Figure 14. Global Denosumab Injection Revenue Market Share by Type (2021-2026)
Figure 15. Denosumab Injection Consumed in Giant Cell Tumor of Bone
Figure 16. Global Denosumab Injection Market: Giant Cell Tumor of Bone (2021-2026) & (K Units)
Figure 17. Denosumab Injection Consumed in Multiple Myeloma
Figure 18. Global Denosumab Injection Market: Multiple Myeloma (2021-2026) & (K Units)
Figure 19. Denosumab Injection Consumed in Hypercalcemia of Malignant Tumors
Figure 20. Global Denosumab Injection Market: Hypercalcemia of Malignant Tumors (2021-2026) & (K Units)
Figure 21. Denosumab Injection Consumed in Osteolytic Bone Metastasis of Solid Tumors
Figure 22. Global Denosumab Injection Market: Osteolytic Bone Metastasis of Solid Tumors (2021-2026) & (K Units)
Figure 23. Global Denosumab Injection Sale Market Share by Application (2025)
Figure 24. Global Denosumab Injection Revenue Market Share by Application in 2026
Figure 25. Denosumab Injection Sales by Company in 2026 (K Units)
Figure 26. Global Denosumab Injection Sales Market Share by Company in 2026
Figure 27. Denosumab Injection Revenue by Company in 2026 ($ millions)
Figure 28. Global Denosumab Injection Revenue Market Share by Company in 2026
Figure 29. Global Denosumab Injection Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Denosumab Injection Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Denosumab Injection Sales 2021-2026 (K Units)
Figure 32. Americas Denosumab Injection Revenue 2021-2026 ($ millions)
Figure 33. APAC Denosumab Injection Sales 2021-2026 (K Units)
Figure 34. APAC Denosumab Injection Revenue 2021-2026 ($ millions)
Figure 35. Europe Denosumab Injection Sales 2021-2026 (K Units)
Figure 36. Europe Denosumab Injection Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Denosumab Injection Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Denosumab Injection Revenue 2021-2026 ($ millions)
Figure 39. Americas Denosumab Injection Sales Market Share by Country in 2026
Figure 40. Americas Denosumab Injection Revenue Market Share by Country (2021-2026)
Figure 41. Americas Denosumab Injection Sales Market Share by Type (2021-2026)
Figure 42. Americas Denosumab Injection Sales Market Share by Application (2021-2026)
Figure 43. United States Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Denosumab Injection Sales Market Share by Region in 2026
Figure 48. APAC Denosumab Injection Revenue Market Share by Region (2021-2026)
Figure 49. APAC Denosumab Injection Sales Market Share by Type (2021-2026)
Figure 50. APAC Denosumab Injection Sales Market Share by Application (2021-2026)
Figure 51. China Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. India Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Denosumab Injection Sales Market Share by Country in 2026
Figure 59. Europe Denosumab Injection Revenue Market Share by Country (2021-2026)
Figure 60. Europe Denosumab Injection Sales Market Share by Type (2021-2026)
Figure 61. Europe Denosumab Injection Sales Market Share by Application (2021-2026)
Figure 62. Germany Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. France Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Denosumab Injection Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Denosumab Injection Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Denosumab Injection Sales Market Share by Application (2021-2026)
Figure 70. Egypt Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Denosumab Injection in 2026
Figure 76. Manufacturing Process Analysis of Denosumab Injection
Figure 77. Industry Chain Structure of Denosumab Injection
Figure 78. Channels of Distribution
Figure 79. Global Denosumab Injection Sales Market Forecast by Region (2027-2032)
Figure 80. Global Denosumab Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Denosumab Injection Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Denosumab Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Denosumab Injection Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Denosumab Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Denosumab Injection
Figure 2. Denosumab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Denosumab Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Denosumab Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Denosumab Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Denosumab Injection Sales Market Share by Country/Region (2025)
Figure 10. Denosumab Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 60mg per Vial
Figure 12. Product Picture of 120mg per Vial
Figure 13. Global Denosumab Injection Sales Market Share by Type in 2026
Figure 14. Global Denosumab Injection Revenue Market Share by Type (2021-2026)
Figure 15. Denosumab Injection Consumed in Giant Cell Tumor of Bone
Figure 16. Global Denosumab Injection Market: Giant Cell Tumor of Bone (2021-2026) & (K Units)
Figure 17. Denosumab Injection Consumed in Multiple Myeloma
Figure 18. Global Denosumab Injection Market: Multiple Myeloma (2021-2026) & (K Units)
Figure 19. Denosumab Injection Consumed in Hypercalcemia of Malignant Tumors
Figure 20. Global Denosumab Injection Market: Hypercalcemia of Malignant Tumors (2021-2026) & (K Units)
Figure 21. Denosumab Injection Consumed in Osteolytic Bone Metastasis of Solid Tumors
Figure 22. Global Denosumab Injection Market: Osteolytic Bone Metastasis of Solid Tumors (2021-2026) & (K Units)
Figure 23. Global Denosumab Injection Sale Market Share by Application (2025)
Figure 24. Global Denosumab Injection Revenue Market Share by Application in 2026
Figure 25. Denosumab Injection Sales by Company in 2026 (K Units)
Figure 26. Global Denosumab Injection Sales Market Share by Company in 2026
Figure 27. Denosumab Injection Revenue by Company in 2026 ($ millions)
Figure 28. Global Denosumab Injection Revenue Market Share by Company in 2026
Figure 29. Global Denosumab Injection Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Denosumab Injection Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Denosumab Injection Sales 2021-2026 (K Units)
Figure 32. Americas Denosumab Injection Revenue 2021-2026 ($ millions)
Figure 33. APAC Denosumab Injection Sales 2021-2026 (K Units)
Figure 34. APAC Denosumab Injection Revenue 2021-2026 ($ millions)
Figure 35. Europe Denosumab Injection Sales 2021-2026 (K Units)
Figure 36. Europe Denosumab Injection Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Denosumab Injection Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Denosumab Injection Revenue 2021-2026 ($ millions)
Figure 39. Americas Denosumab Injection Sales Market Share by Country in 2026
Figure 40. Americas Denosumab Injection Revenue Market Share by Country (2021-2026)
Figure 41. Americas Denosumab Injection Sales Market Share by Type (2021-2026)
Figure 42. Americas Denosumab Injection Sales Market Share by Application (2021-2026)
Figure 43. United States Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Denosumab Injection Sales Market Share by Region in 2026
Figure 48. APAC Denosumab Injection Revenue Market Share by Region (2021-2026)
Figure 49. APAC Denosumab Injection Sales Market Share by Type (2021-2026)
Figure 50. APAC Denosumab Injection Sales Market Share by Application (2021-2026)
Figure 51. China Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. India Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Denosumab Injection Sales Market Share by Country in 2026
Figure 59. Europe Denosumab Injection Revenue Market Share by Country (2021-2026)
Figure 60. Europe Denosumab Injection Sales Market Share by Type (2021-2026)
Figure 61. Europe Denosumab Injection Sales Market Share by Application (2021-2026)
Figure 62. Germany Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. France Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Denosumab Injection Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Denosumab Injection Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Denosumab Injection Sales Market Share by Application (2021-2026)
Figure 70. Egypt Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Denosumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Denosumab Injection in 2026
Figure 76. Manufacturing Process Analysis of Denosumab Injection
Figure 77. Industry Chain Structure of Denosumab Injection
Figure 78. Channels of Distribution
Figure 79. Global Denosumab Injection Sales Market Forecast by Region (2027-2032)
Figure 80. Global Denosumab Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Denosumab Injection Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Denosumab Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Denosumab Injection Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Denosumab Injection Revenue Market Share Forecast by Application (2027-2032)
